Literature DB >> 7414554

At III content and antithrombin in activity in oestrogen-progestogen and progestogen-only treated women.

J Conard, B Cazenave, M Samama, M H Horellou, J R Zorn, C Neau.   

Abstract

Entities:  

Keywords:  Comparative Studies; Contraception; Contraceptive Agents, Estrogen--administraction and dosage; Contraceptive Agents, Estrogen--side effects; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--administraction and dosage; Contraceptive Agents--side effects; Ethinyl Estradiol--administraction and dosage; Ethinyl Estradiol--side effects; Family Planning; Oral Contraceptives; Oral Contraceptives, Combined; Research Methodology; Studies

Mesh：

Substances：

Year:  1980        PMID： 7414554     DOI： 10.1016/0049-3848(80)90222-4

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  3 in total

1.  Hormone replacement therapy and its influence on AT-III activity in climacteric women.

Authors:  H Enzelsberger; G Heytmanek; C Kurz; M Metka
Journal:  Klin Wochenschr       Date:  1991-03-18

2.  Cyclic hormonal replacement therapy after the menopause: transdermal versus oral treatment.

Authors:  M Cortellaro; T Nencioni; C Boschetti; S Ortolani; F Buzzi; B Francucci; M P Caraceni; P Abelli; F Polvani; C Zanussi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Transdermal estradiol substitution therapy for the induction of puberty in female hypogonadism.

Authors:  M Cisternino; K Nahoul; M Bozzola; G Grignani; G Perani; P Sampaolo; M Roger; F Severi
Journal:  J Endocrinol Invest       Date:  1991-06       Impact factor: 4.256
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.